Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cardiac Resynchronization Therapy (CRT) Implant Strategy Using the Longest Electrical Delay for Non-left Bundle Branch Block Patients (ENHANCE CRT). A Prospective, Randomized, Postmarket, Pilot Study.

NCT01983293 is registered in ClinicalTrials.gov with Abbott Medical Devices as lead sponsor.

NCT NCT01983293
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01983293 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cardiac Resynchronization Therapy (CRT) Implant Strategy Using the Longest Electrical Delay for Non-left Bundle Branch Block Patients (ENHANCE CRT). A Prospective, Randomized, Postmarket, Pilot Study.
Lead sponsor
Abbott Medical Devices
Phase
Not applicable
Overall status
Completed
Start date
November 30, 2013
Completion date
January 31, 2018
Enrollment
248 (actual)
Sites
32

Conditions

As the registry lists them; a condition with its own page is linked.

ischemic or non-ischemic cardiomyopathy, non-left bundle branch block